WS Management’s Editas Medicine EDIT Stock Holding History
Bought
Maintained
Sold
Other funds holding EDIT
DTC
WS Management's EDIT Position: Q1 2024 in Review
WS Management sold out of Editas Medicine (EDIT) in Q1 2024, closing a stake of 28,797 shares — an estimated $292K sold.
WS Management first reported a position in EDIT in Q2 2018 and held it in 23 quarters. The position peaked at $3.11M in Q2 2018. 225 funds tracked by Wall St. Rank hold EDIT as of Q1 2024.
- WS Management reported no remaining Editas Medicine position as of Q1 2024 after selling out during the quarter.
- WS Management sold 28,797 Editas Medicine shares in Q1 2024, an estimated $292K.
- WS Management first reported a position in Editas Medicine in Q2 2018 and held it in 23 quarters.
- WS Management's Editas Medicine position peaked at $3.11M in Q2 2018.
- 225 funds tracked by Wall St. Rank held Editas Medicine as of Q1 2024.
Based on WS Management's 13F filing for Q1 2024, filed 14 May 2024.